Genetic Studies on Diabetic Microvascular Complications: Focusing on Genome-Wide Association Studies

Diabetes is a common metabolic disorder with a worldwide prevalence of 8.3% and is the leading cause of visual loss, end-stage renal disease and amputation. Recently, genome-wide association studies (GWASs) have identified genetic risk factors for diabetic microvascular complications of retinopathy,...

Full description

Bibliographic Details
Main Authors: Soo Heon Kwak, Kyong Soo Park
Format: Article
Language:English
Published: Academya Publishing Co. 2015-06-01
Series:Endocrinology and Metabolism
Subjects:
Online Access:http://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-30-147.pdf
id doaj-a14ad4d0d5e44b9c8899307c5ff78a34
record_format Article
spelling doaj-a14ad4d0d5e44b9c8899307c5ff78a342020-11-24T23:29:36ZengAcademya Publishing Co.Endocrinology and Metabolism2093-596X2093-59782015-06-0130214715810.3803/EnM.2015.30.2.14720797Genetic Studies on Diabetic Microvascular Complications: Focusing on Genome-Wide Association StudiesSoo Heon KwakKyong Soo ParkDiabetes is a common metabolic disorder with a worldwide prevalence of 8.3% and is the leading cause of visual loss, end-stage renal disease and amputation. Recently, genome-wide association studies (GWASs) have identified genetic risk factors for diabetic microvascular complications of retinopathy, nephropathy, and neuropathy. We summarized the recent findings of GWASs on diabetic microvascular complications and highlighted the challenges and our opinion on future directives. Five GWASs were conducted on diabetic retinopathy, nine on nephropathy, and one on neuropathic pain. The majority of recent GWASs were underpowered and heterogeneous in terms of study design, inclusion criteria and phenotype definition. Therefore, few reached the genome-wide significance threshold and the findings were inconsistent across the studies. Recent GWASs provided novel information on genetic risk factors and the possible pathophysiology of diabetic microvascular complications. However, further collaborative efforts to standardize phenotype definition and increase sample size are necessary for successful genetic studies on diabetic microvascular complications.http://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-30-147.pdfDiabetesMicrovascular complicationRetinopathyNephropathyNeuropathyGenome-wide association studyGenetics
collection DOAJ
language English
format Article
sources DOAJ
author Soo Heon Kwak
Kyong Soo Park
spellingShingle Soo Heon Kwak
Kyong Soo Park
Genetic Studies on Diabetic Microvascular Complications: Focusing on Genome-Wide Association Studies
Endocrinology and Metabolism
Diabetes
Microvascular complication
Retinopathy
Nephropathy
Neuropathy
Genome-wide association study
Genetics
author_facet Soo Heon Kwak
Kyong Soo Park
author_sort Soo Heon Kwak
title Genetic Studies on Diabetic Microvascular Complications: Focusing on Genome-Wide Association Studies
title_short Genetic Studies on Diabetic Microvascular Complications: Focusing on Genome-Wide Association Studies
title_full Genetic Studies on Diabetic Microvascular Complications: Focusing on Genome-Wide Association Studies
title_fullStr Genetic Studies on Diabetic Microvascular Complications: Focusing on Genome-Wide Association Studies
title_full_unstemmed Genetic Studies on Diabetic Microvascular Complications: Focusing on Genome-Wide Association Studies
title_sort genetic studies on diabetic microvascular complications: focusing on genome-wide association studies
publisher Academya Publishing Co.
series Endocrinology and Metabolism
issn 2093-596X
2093-5978
publishDate 2015-06-01
description Diabetes is a common metabolic disorder with a worldwide prevalence of 8.3% and is the leading cause of visual loss, end-stage renal disease and amputation. Recently, genome-wide association studies (GWASs) have identified genetic risk factors for diabetic microvascular complications of retinopathy, nephropathy, and neuropathy. We summarized the recent findings of GWASs on diabetic microvascular complications and highlighted the challenges and our opinion on future directives. Five GWASs were conducted on diabetic retinopathy, nine on nephropathy, and one on neuropathic pain. The majority of recent GWASs were underpowered and heterogeneous in terms of study design, inclusion criteria and phenotype definition. Therefore, few reached the genome-wide significance threshold and the findings were inconsistent across the studies. Recent GWASs provided novel information on genetic risk factors and the possible pathophysiology of diabetic microvascular complications. However, further collaborative efforts to standardize phenotype definition and increase sample size are necessary for successful genetic studies on diabetic microvascular complications.
topic Diabetes
Microvascular complication
Retinopathy
Nephropathy
Neuropathy
Genome-wide association study
Genetics
url http://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-30-147.pdf
work_keys_str_mv AT sooheonkwak geneticstudiesondiabeticmicrovascularcomplicationsfocusingongenomewideassociationstudies
AT kyongsoopark geneticstudiesondiabeticmicrovascularcomplicationsfocusingongenomewideassociationstudies
_version_ 1725544785198972928